Skip to content


Vyondys (golodirsen) is an oligonucleotide pharmaceutical. Golodirsen was first approved as Vyondys on 2019-12-12. It is used to treat duchenne muscular dystrophy in the USA. Vyondys 53's patents are valid until 2025-06-28 (FDA).
Trade Name Vyondys
Common Name Golodirsen
Indication duchenne muscular dystrophy
Drug Class Antisense oligonucleotides
Get full access now